Logo image of NOV

NOV INC (NOV) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:NOV - US62955J1034 - Common Stock

18 USD
-0.02 (-0.11%)
Last: 1/16/2026, 8:04:00 PM
18 USD
0 (0%)
After Hours: 1/16/2026, 8:04:00 PM
Fundamental Rating

4

NOV gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 62 industry peers in the Energy Equipment & Services industry. NOV has an average financial health and profitability rating. NOV has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year NOV was profitable.
  • NOV had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: NOV reported negative net income in multiple years.
  • Of the past 5 years NOV 4 years had a positive operating cash flow.
NOV Yearly Net Income VS EBIT VS OCF VS FCFNOV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2B -4B -6B

1.2 Ratios

  • NOV has a Return On Assets of 3.38%. This is comparable to the rest of the industry: NOV outperforms 58.06% of its industry peers.
  • The Return On Equity of NOV (5.93%) is comparable to the rest of the industry.
  • The Return On Invested Capital of NOV (5.95%) is comparable to the rest of the industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for NOV is significantly below the industry average of 12.77%.
  • The 3 year average ROIC (5.23%) for NOV is below the current ROIC(5.95%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.38%
ROE 5.93%
ROIC 5.95%
ROA(3y)5.3%
ROA(5y)-2.46%
ROE(3y)9.7%
ROE(5y)-4.94%
ROIC(3y)5.23%
ROIC(5y)N/A
NOV Yearly ROA, ROE, ROICNOV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

  • The Profit Margin of NOV (4.36%) is comparable to the rest of the industry.
  • NOV has a Operating Margin of 8.05%. This is comparable to the rest of the industry: NOV outperforms 50.00% of its industry peers.
  • Looking at the Gross Margin, with a value of 21.46%, NOV is doing worse than 61.29% of the companies in the same industry.
  • NOV's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 8.05%
PM (TTM) 4.36%
GM 21.46%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y17.38%
GM growth 5Y17.86%
NOV Yearly Profit, Operating, Gross MarginsNOV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

6

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NOV is destroying value.
  • The number of shares outstanding for NOV has been reduced compared to 1 year ago.
  • The number of shares outstanding for NOV has been reduced compared to 5 years ago.
  • The debt/assets ratio for NOV is higher compared to a year ago.
NOV Yearly Shares OutstandingNOV Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
NOV Yearly Total Debt VS Total AssetsNOV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

  • An Altman-Z score of 2.09 indicates that NOV is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • NOV's Altman-Z score of 2.09 is in line compared to the rest of the industry. NOV outperforms 51.61% of its industry peers.
  • NOV has a debt to FCF ratio of 2.28. This is a good value and a sign of high solvency as NOV would need 2.28 years to pay back of all of its debts.
  • With a decent Debt to FCF ratio value of 2.28, NOV is doing good in the industry, outperforming 72.58% of the companies in the same industry.
  • A Debt/Equity ratio of 0.30 indicates that NOV is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.30, NOV is in the better half of the industry, outperforming 64.52% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 2.28
Altman-Z 2.09
ROIC/WACC0.73
WACC8.15%
NOV Yearly LT Debt VS Equity VS FCFNOV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

  • A Current Ratio of 2.55 indicates that NOV has no problem at all paying its short term obligations.
  • NOV has a Current ratio of 2.55. This is in the better half of the industry: NOV outperforms 79.03% of its industry peers.
  • A Quick Ratio of 1.71 indicates that NOV should not have too much problems paying its short term obligations.
  • With a decent Quick ratio value of 1.71, NOV is doing good in the industry, outperforming 62.90% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.55
Quick Ratio 1.71
NOV Yearly Current Assets VS Current LiabilitesNOV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

3

3. Growth

3.1 Past

  • NOV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -32.43%.
  • NOV shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 40.89% yearly.
  • The Revenue has decreased by -1.46% in the past year.
  • The Revenue has been growing slightly by 0.91% on average over the past years.
EPS 1Y (TTM)-32.43%
EPS 3YN/A
EPS 5Y40.89%
EPS Q2Q%-66.67%
Revenue 1Y (TTM)-1.46%
Revenue growth 3Y17.1%
Revenue growth 5Y0.91%
Sales Q2Q%-0.68%

3.2 Future

  • The Earnings Per Share is expected to decrease by -0.24% on average over the next years.
  • NOV is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.66% yearly.
EPS Next Y-41.57%
EPS Next 2Y-16.01%
EPS Next 3Y-5.97%
EPS Next 5Y-0.24%
Revenue Next Year-1.99%
Revenue Next 2Y-1.32%
Revenue Next 3Y0.22%
Revenue Next 5Y1.66%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
NOV Yearly Revenue VS EstimatesNOV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B
NOV Yearly EPS VS EstimatesNOV Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1 2

4

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 18.00, NOV is valued on the expensive side.
  • Compared to the rest of the industry, the Price/Earnings ratio of NOV indicates a somewhat cheap valuation: NOV is cheaper than 75.81% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.47. NOV is valued slightly cheaper when compared to this.
  • Based on the Price/Forward Earnings ratio of 15.85, the valuation of NOV can be described as correct.
  • NOV's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. NOV is cheaper than 67.74% of the companies in the same industry.
  • NOV is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 24.26, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 18
Fwd PE 15.85
NOV Price Earnings VS Forward Price EarningsNOV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • NOV's Enterprise Value to EBITDA ratio is in line with the industry average.
  • NOV's Price/Free Cash Flow ratio is rather cheap when compared to the industry. NOV is cheaper than 90.32% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.49
EV/EBITDA 6.95
NOV Per share dataNOV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • NOV's earnings are expected to decrease with -5.97% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.44
EPS Next 2Y-16.01%
EPS Next 3Y-5.97%

5

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 1.71%, NOV has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 1.21, NOV pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.89, NOV has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.71%

5.2 History

  • The dividend of NOV is nicely growing with an annual growth rate of 6.81%!
  • NOV has been paying a dividend for at least 10 years, so it has a reliable track record.
  • NOV has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)6.81%
Div Incr Years2
Div Non Decr Years5
NOV Yearly Dividends per shareNOV Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

  • 50.13% of the earnings are spent on dividend by NOV. This is a bit on the high side, but may be sustainable.
  • The Dividend Rate of NOV has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP50.13%
EPS Next 2Y-16.01%
EPS Next 3Y-5.97%
NOV Yearly Income VS Free CF VS DividendNOV Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2B -4B -6B
NOV Dividend Payout.NOV Dividend Payout, showing the Payout Ratio.NOV Dividend Payout.PayoutRetained Earnings

NOV INC

NYSE:NOV (1/16/2026, 8:04:00 PM)

After market: 18 0 (0%)

18

-0.02 (-0.11%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)10-27
Earnings (Next)02-04
Inst Owners109.49%
Inst Owner Change0.01%
Ins Owners0.4%
Ins Owner Change-0.58%
Market Cap6.57B
Revenue(TTM)8.78B
Net Income(TTM)383.00M
Analysts71.2
Price Target17.1 (-5%)
Short Float %6.07%
Short Ratio5.16
Dividend
Industry RankSector Rank
Dividend Yield 1.71%
Yearly Dividend0.28
Dividend Growth(5Y)6.81%
DP50.13%
Div Incr Years2
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-29.49%
Min EPS beat(2)-56.61%
Max EPS beat(2)-2.37%
EPS beat(4)1
Avg EPS beat(4)-18.66%
Min EPS beat(4)-56.61%
Max EPS beat(4)10.12%
EPS beat(8)3
Avg EPS beat(8)-5.6%
EPS beat(12)6
Avg EPS beat(12)1.81%
EPS beat(16)8
Avg EPS beat(16)23.76%
Revenue beat(2)2
Avg Revenue beat(2)0.85%
Min Revenue beat(2)0.65%
Max Revenue beat(2)1.06%
Revenue beat(4)3
Avg Revenue beat(4)0.7%
Min Revenue beat(4)-0.85%
Max Revenue beat(4)1.94%
Revenue beat(8)6
Avg Revenue beat(8)0.48%
Revenue beat(12)8
Avg Revenue beat(12)0.8%
Revenue beat(16)12
Avg Revenue beat(16)1.25%
PT rev (1m)1.6%
PT rev (3m)9.72%
EPS NQ rev (1m)0.23%
EPS NQ rev (3m)-6.44%
EPS NY rev (1m)1.14%
EPS NY rev (3m)-11.15%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.27%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.47%
Valuation
Industry RankSector Rank
PE 18
Fwd PE 15.85
P/S 0.75
P/FCF 7.49
P/OCF 5.17
P/B 1.02
P/tB 1.5
EV/EBITDA 6.95
EPS(TTM)1
EY5.56%
EPS(NY)1.14
Fwd EY6.31%
FCF(TTM)2.4
FCFY13.36%
OCF(TTM)3.48
OCFY19.33%
SpS24.06
BVpS17.7
TBVpS11.97
PEG (NY)N/A
PEG (5Y)0.44
Graham Number19.95
Profitability
Industry RankSector Rank
ROA 3.38%
ROE 5.93%
ROCE 7.78%
ROIC 5.95%
ROICexc 6.86%
ROICexgc 9.34%
OM 8.05%
PM (TTM) 4.36%
GM 21.46%
FCFM 9.99%
ROA(3y)5.3%
ROA(5y)-2.46%
ROE(3y)9.7%
ROE(5y)-4.94%
ROIC(3y)5.23%
ROIC(5y)N/A
ROICexc(3y)5.95%
ROICexc(5y)N/A
ROICexgc(3y)8.17%
ROICexgc(5y)N/A
ROCE(3y)6.84%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y17.38%
GM growth 5Y17.86%
F-Score4
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 2.28
Debt/EBITDA 1.82
Cap/Depr 111.05%
Cap/Sales 4.47%
Interest Coverage 8.31
Cash Conversion 119.83%
Profit Quality 228.98%
Current Ratio 2.55
Quick Ratio 1.71
Altman-Z 2.09
F-Score4
WACC8.15%
ROIC/WACC0.73
Cap/Depr(3y)89.05%
Cap/Depr(5y)79.41%
Cap/Sales(3y)3.4%
Cap/Sales(5y)3.51%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-32.43%
EPS 3YN/A
EPS 5Y40.89%
EPS Q2Q%-66.67%
EPS Next Y-41.57%
EPS Next 2Y-16.01%
EPS Next 3Y-5.97%
EPS Next 5Y-0.24%
Revenue 1Y (TTM)-1.46%
Revenue growth 3Y17.1%
Revenue growth 5Y0.91%
Sales Q2Q%-0.68%
Revenue Next Year-1.99%
Revenue Next 2Y-1.32%
Revenue Next 3Y0.22%
Revenue Next 5Y1.66%
EBIT growth 1Y-14.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year25.4%
EBIT Next 3Y9.95%
EBIT Next 5Y7.01%
FCF growth 1Y348.44%
FCF growth 3Y119.59%
FCF growth 5Y14.65%
OCF growth 1Y1686.25%
OCF growth 3Y64.86%
OCF growth 5Y12.8%

NOV INC / NOV FAQ

What is the fundamental rating for NOV stock?

ChartMill assigns a fundamental rating of 4 / 10 to NOV.


Can you provide the valuation status for NOV INC?

ChartMill assigns a valuation rating of 4 / 10 to NOV INC (NOV). This can be considered as Fairly Valued.


What is the profitability of NOV stock?

NOV INC (NOV) has a profitability rating of 4 / 10.


Can you provide the expected EPS growth for NOV stock?

The Earnings per Share (EPS) of NOV INC (NOV) is expected to decline by -41.57% in the next year.


Is the dividend of NOV INC sustainable?

The dividend rating of NOV INC (NOV) is 5 / 10 and the dividend payout ratio is 50.13%.